HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Extract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (71) Citing Articles via Google Scholar Google Scholar Articles by Poon, L. L.M. Articles by Lo, Y.M. D. Search for Related Content PubMed PubMed Citation Articles by Poon, L. L.M. Articles by Lo, Y.M. D. Related Collections Molecular Diagnostics and Genetics

Presence of Fetal RNA in Maternal Plasma

Departments of
¹ Chemical Pathology and
² Obstetrics and Gynecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR
^a address correspondence to this author at: Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Room 38023, 1/F Clinical Sciences Building, 30-32 Ngan Shing Street, Shatin, New Territories, Hong Kong SAR; fax 852-2194-6171, e-mail loym{at}cuhk.edu.hk

	Introduction

Top Introduction References

 
The discovery of fetal DNA in maternal plasma (1) has opened up a new horizon on prenatal molecular diagnosis. Many groups have since shown that fetal genetic traits, such as RhD status and inherited genetic diseases, can be determined from fetal DNA in maternal plasma (2)(3)(4)(5). However, it is not known whether fetal RNA is also present in maternal plasma. Here, using a two-step reverse transcription (RT)-PCR assay, we demonstrate the presence of fetal-derived, male-specific mRNA in plasma of pregnant women carrying male fetuses.

Pregnant women attending the Prenatal Diagnosis Unit at the Department of Obstetrics and Gynecology, Prince of Wales Hospital, Hong Kong were recruited with informed consent. The study was approved by the Clinical Research Ethics Committee. Women early and late in their pregnancies (n = 21 and 37, respectively) were recruited in this study. The mean gestational ages of the subjects in early and late pregnancies were 16 weeks (range, 11–19 weeks) and 33 weeks (range, 26–40 weeks), respectively. All early-pregnancy samples were obtained before any invasive procedure. On the other hand, late-pregnancy samples were collected either from women who had invasive procedures in early pregnancy (n = 21) or from women who did not have any prenatal invasive procedure (n = 16). All plasma samples were harvested within 30 min from EDTA-blood samples as described previously (1). Total RNA from plasma samples was isolated with the Trizol LS Reagent (Life Technologies) as instructed by the manufacturer. In general, RNA isolated from 1 mL of plasma was dissolved in 50 µL of RNase-free water.

In this study, we chose to detect fetal-derived, Y-chromosome-specific zinc finger protein (ZFY) mRNA (6)(7) in maternal plasma. As shown in Fig. 1 , RT-PCR products corresponding to ZFY mRNA were observed only when male placental total RNA was used in the RT-PCR assay (Fig. 1 , lane 1). By contrast, no positive signal was detected when either reverse transcriptase was omitted (Fig. 1 , lane 2) or female placental total RNA was used (Fig. 1 , lane 3) in the RT-PCR assays. Among 20 women carrying male fetuses in late pregnancy, ZFY-positive signals were detected (Fig. 1 , middle panel, lanes 6–10) in 13 plasma samples. Positive signals were observed in two of nine women carrying male fetuses in early pregnancy. The identities of ZFY mRNA-specific RT-PCR products in the positive cases were confirmed by DNA sequencing (data not shown). By contrast, of 20 women carrying female fetuses either in early (n = 12) or in late (n = 8) pregnancy, all but 1 case were negative in the assay (Fig. 1 , middle panel, lanes 11–14). The only false-positive case was presumably attributable to contamination during RNA processing. As a control for the quality of the extracted RNA, we also subjected all samples to a RT-PCR assay for HLA-G mRNA (8). The HLA-G gene is expressed by both fetal [e.g., trophoblasts (8)] and maternal [e.g., lymphocytes (9)] tissues. As shown in the bottom panel of Fig. 1 , RT-PCR products specific for HLA-G mRNA were detected in all tested plasma samples, demonstrating the presence of amplifiable RNA in these samples.

View larger version (97K): [in this window] [in a new window]   Figure 1. Detection of fetal ZFY mRNA from maternal plasma. Lane 1, positive control; lanes 2–5, negative controls as indicated; lanes 6–10, RNA isolated from women carrying male fetuses; lanes 11–14, RNA isolated from women carrying female fetuses; lane 14, water control. RT-PCR products of ZFY (89 bp) and HLA-G (246 bp) mRNA are indicated. M, DNA markers. To convert plasma RNA into cDNA, 10 µL of RNA dissolved in RNase-free water was primed with 100 ng of random primers and reverse-transcribed by Superscript RT II (Life Technologies) according to the manufacturer’s recommendations. The reverse-transcribed products were then amplified by AmpliTaq Gold DNA polymerase (PE Biosystems) as instructed by the manufacturer. To detect ZFY cDNA, a pair of intron-spanning primers specific for ZFY cDNA (forward primer, 5'-GACTACCTAATGATTTCGTTGGATG-3', corresponding to nucleotides 616–641 of ZFY cDNA; reverse primer, 5'-TCCATTTCTGATTCTGCATCG-3', complementary to nucleotides 704–684 of ZFY cDNA) was used in the PCR reactions (50 cycles of 95 °C for 1 min, 56 °C for 1 min, and 72 °C for 30 s). To detect HLA-G cDNA, a pair of intron-spanning primers, 5G2RNA and G3E3, were used in the PCR reaction as described (8).

Recently, it has been demonstrated that a proportion of maternal plasma fetal DNA circulates in the form of intact fetal cells (10). Thus, theoretically it is possible that the fetal RNA that we detected in the current study could have originated from these "plasma-derived" cells. To conclusively test whether fetal RNA can be detected in the "cell-free" form in maternal circulation, maternal plasma samples were filtered by a 0.2 µm membrane (Nalgene), and the RNA extracted from these filtered plasma samples was tested by the ZFY RT-PCR assay. Of nine filtered plasma samples collected from women carrying male fetuses in late pregnancies, positive ZFY mRNA signals were detected in six samples (data not shown). These results indicate that at least a portion of fetal RNA in maternal plasma exists in the cell-free form. This observation is consistent with the recent finding that tumor-derived RNA can be detected in the circulation of cancer patients (11)(12).

Our data demonstrate that fetal RNA can be detected in maternal plasma. The detection rates of plasma fetal RNA in early and late pregnancies were 22% and 63%, respectively. The detection rate of fetal RNA in early pregnancy cases was lower than that in late pregnancy cases, suggesting that the concentration of plasma fetal RNA is lower in early pregnancy. This observation is similar to our previous finding that the concentration of fetal DNA in maternal plasma increases with gestation (13). We also realized that the detection rate of plasma fetal RNA in this study is lower than that of plasma fetal DNA (1). It is possible that fetal RNA is more susceptible to degradation in maternal blood. As a result, the amount of fetal RNA in plasma is much lower than plasma fetal DNA. This is supported by the fact that Y-specific DNA was detected in all plasma samples from women carrying male fetuses in this study (data not shown). To improve the sensitivity of maternal plasma fetal RNA detection, we are now developing a highly sensitive real-time quantitative RT-PCR assay for this purpose.

In conclusion, we have shown for the first time that fetal RNA can be detected in maternal plasma, and our data provide a novel means of noninvasive prenatal diagnosis. Plasma fetal DNA analysis can provide data on the presence and concentration of fetal genetic material in the maternal circulation. Plasma fetal RNA analysis, in addition, can provide valuable information regarding the gene expression patterns of fetal tissues. For example, abnormal pregnancies, such as those with preeclampsia, often are associated with abnormal gene expression patterns in fetal tissues (14). Thus, with the development of further RNA markers, maternal plasma RNA analysis may allow the noninvasive monitoring of fetal gene expression in a multitude of physiological and pathological conditions.

	Acknowledgments

 
This work is supported by the Earmarked Research Grants Scheme from the Hong Kong Research Grants Council (CUHK 4255/99M) and a grant from the Industrial Support Fund (AF/90/99).

	References

Top Introduction References

 

1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.[Web of Science][Medline] [Order article via Infotrieve]
2. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.[Abstract/Free Full Text]
3. Faas BHW, Beuling EA, Christiaens GCML, von dem Borne AEGK, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma [Letter]. Lancet 1998;352:1196.[Web of Science][Medline] [Order article via Infotrieve]
4. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma [Technical Brief]. Clin Chem 2000;46:301-302.[Free Full Text]
5. Chen CP, Chern SR, Wang W. Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy [Letter]. Prenat Diagn 2000;20:355-357.[Web of Science][Medline] [Order article via Infotrieve]
6. Page DC, Mosher R, Simpson EM, Fisher EM, Mardon G, Pollack J, et al. The sex-determining region of the human Y chromosome encodes a finger protein. Cell 1987;51:1091-1104.[Web of Science][Medline] [Order article via Infotrieve]
7. Palmer MS, Berta P, Sinclair AH, Pym B, Goodfellow PN. Comparison of human ZFY and ZFX transcripts. Proc Natl Acad Sci U S A 1990;87:1681-1685.[Abstract/Free Full Text]
8. Hviid TVF, Møller C, Sørensen S, Morling N. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Hum Immunol 1998;59:87-98.[Web of Science][Medline] [Order article via Infotrieve]
9. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994;91:4209-4213.[Abstract/Free Full Text]
10. van Wijk IJ, de Hoon AC, Jurhawan R, Tjoa ML, Griffioen S, Mulders MA, et al. Detection of apoptotic fetal cells in plasma of pregnant women [Technical Brief]. Clin Chem 2000;46:729-731.[Free Full Text]
11. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999;5:1961-1965.[Abstract/Free Full Text]
12. Lo KW, Lo YMD, Leung SF, Tsang YS, Chan LYS, Johnson PJ, et al. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma [Technical Brief]. Clin Chem 1999;45:1292-1294.[Free Full Text]
13. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775.[Web of Science][Medline] [Order article via Infotrieve]
14. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN, Jr, Bennett WA. Expression of the placental cytokines tumor necrosis factor , interleukin 1 ß, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999;181:915-920.[Web of Science][Medline] [Order article via Infotrieve]

The following articles in journals at HighWire Press have cited this article:

				S. Huang, H. Li, X. Ding, and C. Xiong Presence and Characterization of Cell-Free Seminal RNA in Healthy Individuals: Implications for Noninvasive Disease Diagnosis and Gene Expression Studies of the Male Reproductive System Clin. Chem., November 1, 2009; 55(11): 1967 - 1976. [Abstract] [Full Text] [PDF]

				C. F Wright and L. S Chitty Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing BMJ, July 6, 2009; 339(jul06_2): b2451 - b2451. [Full Text]

				E C W Hung, R W K Chiu, and Y M D Lo Detection of circulating fetal nucleic acids: a review of methods and applications J. Clin. Pathol., April 1, 2009; 62(4): 308 - 313. [Abstract] [Full Text] [PDF]

				C. F. Wright and H. Burton The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis Hum. Reprod. Update, January 1, 2009; 15(1): 139 - 151. [Abstract] [Full Text] [PDF]

				Y. M. Dennis Lo and R. W. K. Chiu Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidies by Maternal Plasma Nucleic Acid Analysis Clin. Chem., March 1, 2008; 54(3): 461 - 466. [Abstract] [Full Text] [PDF]

				S. Rani, M. Clynes, and L. O'Driscoll Detection of Amplifiable mRNA Extracellular to Insulin-Producing Cells: Potential for Predicting Beta Cell Mass and Function Clin. Chem., November 1, 2007; 53(11): 1936 - 1944. [Abstract] [Full Text] [PDF]

				Y. Purwosunu, A. Sekizawa, K. Koide, A. Farina, N. Wibowo, G. H. Wiknjosastro, S. Okazaki, H. Chiba, and T. Okai Cell-Free mRNA Concentrations of Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator Are Increased in the Plasma of Pregnant Women with Preeclampsia Clin. Chem., March 1, 2007; 53(3): 399 - 404. [Abstract] [Full Text] [PDF]

				B. C.K. Wong, R. W.K. Chiu, N. B.Y. Tsui, K.C. A. Chan, L. W. Chan, T. K. Lau, T. N. Leung, and Y.M. D. Lo Circulating Placental RNA in Maternal Plasma Is Associated with a Preponderance of 5' mRNA Fragments: Implications for Noninvasive Prenatal Diagnosis and Monitoring Clin. Chem., October 1, 2005; 51(10): 1786 - 1795. [Abstract] [Full Text] [PDF]

				P. B. Larrabee, K. L. Johnson, I. Peter, and D. W. Bianchi Presence of Filterable and Nonfilterable Cell-Free mRNA in Amniotic Fluid Clin. Chem., June 1, 2005; 51(6): 1024 - 1026. [Full Text] [PDF]

				Y.M. D. Lo Recent Advances in Fetal Nucleic Acids in Maternal Plasma J. Histochem. Cytochem., March 1, 2005; 53(3): 293 - 296. [Abstract] [Full Text] [PDF]

				T. R. Gingeras, R. Higuchi, L. J. Kricka, Y.M. D. Lo, and C. T. Wittwer Fifty Years of Molecular (DNA/RNA) Diagnostics Clin. Chem., March 1, 2005; 51(3): 661 - 671. [Full Text] [PDF]

				P. B. Larrabee, K. L. Johnson, C. Lai, J. Ordovas, J. M. Cowan, U. Tantravahi, and D. W. Bianchi Global Gene Expression Analysis of the Living Human Fetus Using Cell-Free Messenger RNA in Amniotic Fluid JAMA, February 16, 2005; 293(7): 836 - 842. [Abstract] [Full Text] [PDF]

				F. Z. Bischoff, D. E. Lewis, and J. L. Simpson Cell-free fetal DNA in maternal blood: kinetics, source and structure Hum. Reprod. Update, January 1, 2005; 11(1): 59 - 67. [Abstract] [Full Text] [PDF]

				A. K. Gupta, W. Holzgreve, B. Huppertz, A. Malek, H. Schneider, and S. Hahn Detection of Fetal DNA and RNA in Placenta-Derived Syncytiotrophoblast Microparticles Generated in Vitro Clin. Chem., November 1, 2004; 50(11): 2187 - 2190. [Full Text] [PDF]

				E. K.O. Ng, A. El-Sheikhah, R. W.K. Chiu, K.C. A. Chan, M. Hogg, R. Bindra, T. N. Leung, T. K. Lau, K. H. Nicolaides, and Y.M. D. Lo Evaluation of Human Chorionic Gonadotropin {beta}-Subunit mRNA Concentrations in Maternal Serum in Aneuploid Pregnancies: A Feasibility Study Clin. Chem., June 1, 2004; 50(6): 1055 - 1057. [Full Text] [PDF]

				N B Y Tsui, S S C Chim, R W K Chiu, T K Lau, E K O Ng, T N Leung, Y K Tong, K C A Chan, and Y M D Lo Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling J. Med. Genet., June 1, 2004; 41(6): 461 - 467. [Full Text] [PDF]

				K. A. Dukes, L. M. Sullivan, D. Lewis, K. L. Johnson, D. W. Bianchi, J. L. Simpson, W. Holzgreve, S. Hahn, F. Z. Bischoff, and L. G. Jackson The Effect of the Elapsed Time Between Blood Draw and Processing on the Recovery of Fetal Cells From Maternal Blood Reproductive Sciences, April 1, 2004; 11(3): 154 - 165. [Abstract] [PDF]

				C. B.M. Oudejans, A. T.J.J. Go, A. Visser, M. A.M. Mulders, B. A. Westerman, M. A. Blankenstein, and J. M.G. van Vugt Detection of Chromosome 21-encoded mRNA of Placental Origin in Maternal Plasma Clin. Chem., September 1, 2003; 49(9): 1445 - 1449. [Abstract] [Full Text] [PDF]

				J.-M. Costa, A. Benachi, M. Olivi, Y. Dumez, M. Vidaud, and E. Gautier Fetal Expressed Gene Analysis in Maternal Blood: A New Tool for Noninvasive Study of the Fetus Clin. Chem., June 1, 2003; 49(6): 981 - 983. [Full Text] [PDF]

				R. W.K. Chiu, L. Y.S. Chan, N. Y.L. Lam, N. B.Y. Tsui, E. K.O. Ng, T. H. Rainer, and Y.M. D. Lo Quantitative Analysis of Circulating Mitochondrial DNA in Plasma Clin. Chem., May 1, 2003; 49(5): 719 - 726. [Abstract] [Full Text] [PDF]

				E. K.O. Ng, T. N. Leung, N. B.Y. Tsui, T. K. Lau, N. S. Panesar, R. W.K. Chiu, and Y.M. D. Lo The Concentration of Circulating Corticotropin-releasing Hormone mRNA in Maternal Plasma Is Increased in Preeclampsia Clin. Chem., May 1, 2003; 49(5): 727 - 731. [Abstract] [Full Text] [PDF]

				M. A. Ferguson-Smith Placental mRNA in maternal plasma: Prospects for fetal screening PNAS, April 15, 2003; 100(8): 4360 - 4362. [Full Text] [PDF]

				E. K. O. Ng, N. B. Y. Tsui, T. K. Lau, T. N. Leung, R. W. K. Chiu, N. S. Panesar, L. C. W. Lit, K.-W. Chan, and Y. M. D. Lo From the Cover: mRNA of placental origin is readily detectable in maternal plasma PNAS, April 15, 2003; 100(8): 4748 - 4753. [Abstract] [Full Text] [PDF]

				T. V. Hviid In-Cell PCR Method for Specific Genotyping of Genomic DNA from One Individual in a Mixture of Cells from Two Individuals: A Model Study with Specific Relevance to Prenatal Diagnosis Based on Fetal Cells in Maternal Blood Clin. Chem., December 1, 2002; 48(12): 2115 - 2123. [Abstract] [Full Text] [PDF]

				N. B.Y. Tsui, E. K.O. Ng, and Y.M. D. Lo Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma Clin. Chem., October 1, 2002; 48(10): 1647 - 1653. [Abstract] [Full Text] [PDF]

				E. K.O. Ng, N. B.Y. Tsui, N. Y.L. Lam, R. W.K. Chiu, S. C.H. Yu, S.C. C. Wong, E. S.F. Lo, T. H. Rainer, P. J. Johnson, and Y.M. D. Lo Presence of Filterable and Nonfilterable mRNA in the Plasma of Cancer Patients and Healthy Individuals Clin. Chem., August 1, 2002; 48(8): 1212 - 1217. [Abstract] [Full Text] [PDF]

This Article Extract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (71) Citing Articles via Google Scholar Google Scholar Articles by Poon, L. L.M. Articles by Lo, Y.M. D. Search for Related Content PubMed PubMed Citation Articles by Poon, L. L.M. Articles by Lo, Y.M. D. Related Collections Molecular Diagnostics and Genetics